Skip to main content
Premium Trial:

Request an Annual Quote

Craig Mello, Marc Feldman, Ravinder Maini

Premium
RNAi pioneer and Nobel Laureate Craig Mello will chair this year’s Dr. Paul Janssen Award for Biomedical Research Symposium.
 
The symposium is entitled, “Novel Anti-Cytokine Therapies,” and will take place at the New York Academy of Scienceson Sept. 10. The event will honor the winners of the 2008 Dr. Paul Janssen Award for Biomedical Research, Marc Feldman and Ravinder Maini, who discovered tumor necrosis factor-alpha as a target for rheumatoid arthritis and other inflammatory diseases.
 
Established by Johnson & Johnson in 2004 and given every two years, the award honors Paul Janssen, who founded Janssen Pharmaceutical in 1953 prior to its acquisition by J&J. The award includes a $100,000 prize and recognizes the work of individuals who have “made a significant, transformational contribution toward the improvement of human health,” according to J&J.
 
Mello was on the selection committee for this year’s award.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.